Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
British Journal of Cancer|July 1, 1995
CRC/EORTC/NCI Joint Formulation Working Party: experiences in the formulation of investigational cytotoxic drugsJ H Beijnen, K P Flora, G W Halbert, et al.
The Journal of Pharmacy and Pharmacology|May 10, 2002
Development of a lyophilised RH1 formulation: a novel DT diaphorase activated alkylating agentM A Elliott, S J Ford, A A Walker, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 26, 2020
Multidimensional analysis of human intestinal fluid compositionKate Pyper, Joachim Brouwers, Patrick Augustijns, et al.
International Journal of Pharmaceutics|January 31, 2012
Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for Phase I clinical trialM A Elliott, S J Ford, E Prasad, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials CommitteeD M Vigushin, G K Poon, A Boddy, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systemsD J Kerr, T E Wheldon, J G Russell, et al.
International Journal of Cancer|November 4, 1996
Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamolH M Coley, M Jarman, N Brooks, et al.
British Journal of Cancer|June 12, 2003
Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agentM B Jameson, P I Thompson, B C Baguley, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2004
A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifenS R D Johnston, L A Gumbrell, T R J Evans, et al.
Pageof 3